Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 1;19(12):1527-1536.
doi: 10.2215/CJN.0000000000000557. Epub 2024 Sep 12.

Bioimpedance-Guided Fluid Removal in Continuous KRT: The VENUS Randomized Clinical Trial

Jung Nam An  1 , Hyung Jung Oh  2   3 , Sohee Oh  4 , Harin Rhee  5 , Eun Young Seong  5 , Seon Ha Baek  6 , Shin Young Ahn  7 , Jang-Hee Cho  8 , Jung Pyo Lee  3   9 , Dong Ki Kim  3   10 , Dong-Ryeol Ryu  11 , Soyeon Ahn  12 , Sejoong Kim  3   13
Affiliations

Bioimpedance-Guided Fluid Removal in Continuous KRT: The VENUS Randomized Clinical Trial

Jung Nam An et al. Clin J Am Soc Nephrol. .

Abstract

Key Points:

  1. This study, the sole randomized trial of its kind, proposes guidelines for fluid balance management in continuous KRT (CKRT) patients using bioimpedance.

  2. Despite this, bioimpedance analysis–guided volume management did not influence the proportion of patients achieving estimated euvolemia at 7 days into CKRT.

  3. Further investigation is needed to assess whether bioimpedance analysis guidance can facilitate rapid fluid removal in the early phase of CKRT for patients with AKI.

Background: Ultrafiltration with continuous KRT (CKRT) can be used to manage fluid balance in critically ill patients with AKI. We aimed to assess whether bioimpedance analysis (BIA)–guided volume management was more efficacious than conventional management for achieving estimated euvolemia (e-euvolemia) in CKRT-treated patients.

Methods: In a multicenter randomized controlled trial from July 2017 to July 2020, the patients with AKI requiring CKRT were eligible if the weight at the start of CKRT had increased by ≥5% compared with the weight at the time of admission or total body water (TBW)/height (H)2 ≥13 L/m2. We randomly assigned 208 patients to the control (conventional fluid management; n=103) and intervention groups (BIA-guided fluid management; n=105). The primary outcome was the proportion of attaining e-euvolemia 7 days postrandomization. E-euvolemia was defined as the difference between TBW/H2 D7 and D0 was <−2.1 L/m2, or when TBW/H2 measured on D7 was <13 L/m2. The 28-, 60-, and 90-day mortality rate were secondary outcomes.

Results: The primary outcome occurred in 34 patients in the intervention group and 27 in the control group (47% versus 41%; P = 0.50). The mean value of TBW/H2 measured on D7 was the same at 13.9 L/m2 in both groups. The differences between TBW/H2 D7 and D0 were −1.13 L/m2 in the intervention group and −1.08 L/m2 in the control group (P = 0.84). Patients in the intervention group had a significantly higher proportion of reaching e-euvolemia on D1 than those in the control group (13% versus 4%, P = 0.02). Adverse events did not differ significantly between the groups.

Conclusions: BIA-guided volume management did not affect the proportion of reaching the e-euvolemia at 7 days of the start of CKRT.

Clinical Trial registry name and registration number:: ClinicalTrials.gov, ID: NCT03330626 (Registered on November 6, 2017; seven study participants were retrospectively registered; nonetheless, Institutional Review Board approval of each institution was completed before study participant registration).

PubMed Disclaimer

Conflict of interest statement

Disclosure forms, as provided by each author, are available with the online version of the article at http://links.lww.com/CJN/C23.

References

    1. Ronco C Bellomo R Homel P, et al. . Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000;356(9223):26–30. doi:10.1016/S0140-6736(00)02430-2 - DOI - PubMed
    1. Heering P Morgera S Schmitz FJ, et al. . Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care. Med. 1997;23(3):288–296. doi:10.1007/s001340050330 - DOI - PubMed
    1. Uchino S Kellum JA Bellomo R, et al. .; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813–818. doi:10.1001/jama.294.7.813 - DOI - PubMed
    1. Nisula S Kaukonen KM Vaara ST, et al. .; FINNAKI Study Group. Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study. Intensive Care Med. 2013;39(3):420–428. doi:10.1007/s00134-012-2796-5 - DOI - PubMed
    1. Oh HJ Kim MH Ahn JY, et al. . Can early initiation of continuous renal replacement therapy improve patient survival with septic acute kidney injury when enrolled in early goal-directed therapy? J Crit Care. 2016;35:51–56. doi:10.1016/j.jcrc.2016.04.032 - DOI - PubMed

LinkOut - more resources